Aurobindo Pharma gains on receiving USFDA nod for Famotidine Tablets

28 Apr 2016 Evaluate

Aurobindo Pharma is currently trading at Rs. 766.55, up by 1.95 points or 0.26% from its previous closing of Rs. 764.60 on the BSE.

The scrip opened at Rs. 764.00 and has touched a high and low of Rs. 778.95 and Rs. 763.00 respectively. So far 39714 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.50 on 30-Dec-2015 and a 52 week low of Rs. 582.00 on 25-Feb-2016.

Last one week high and low of the scrip stood at Rs. 789.00 and Rs. 758.95 respectively. The current market cap of the company is Rs. 45087.32 crore.

The promoters holding in the company stood at 53.79% while Institutions and Non-Institutions held 34.67% and 11.54% respectively.

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Famotidine Tablets USP, 10 mg and 20 mg (OTC). This product is expected to be launched in Q2 FY16-17. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Pepcid AC Tablets, 10 mg and 20 mg, of McNeil Consumer Pharmaceuticals Co.

Famotidine Tablets (OTC) is used to relieve heartburn associated with acid indigestion and sour stomach. The approved product has an estimated market size of $31 million for the twelve months ending February 2016.

This is the 73rd ANDA (including 16 tentative approvals) to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products. Aurobindo now has a total of 256 ANDA approvals (219 Final approvals including 10 from Aurolife Pharma LLC and 37 tentative approvals) from USFDA.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1167.20 -5.10 (-0.44%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×